Vaccine strategies aimed at generating a CD8+ T cell-mediated response confer protection against virus challenge in murine [11-14], guinea pig [15,16], and non-human primate [17] models of infection of two Old World arenaviruses, Lassa virus (LASV) and lymphocytic choriomeningitis virus (LCMV). The gene discussed is CD8A; the disease is infection.